Backed by rich industry experience, we are offering 2.5mg Bortezomib Injection IP. This injection is demanded to treat people with multiple myeloma. Available in various packaging options, we provide this 2.5mg Bortezomib Injection IP in different quantities. This medication generally comes in a class of medications called antineoplastic agents and also used demanded to treat people with mantle cell lymphoma.
Specification
Shelf life | 2YEARS |
Form | Injection |
Packaging Size | VAIL |
Prescription/Non prescription | Prescription |
Treatment | Bortecad 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It sho |
Manufacturer | Cadila |
Composition | Bortizumib |
Brand | Borticad 2.5mg |
PREEGUS HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |